Suchergebnisse - "Taub, Jeffrey W"

PubPharm (24)

1

Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia

enthalten in: Biochemical pharmacology | 2022

von Hege Hurrish, K. | Qiao, X. | Li, X. | +13

2

The paradox of Myeloid Leukemia associated with Down syndrome

enthalten in: Biochemical pharmacology | 2022

von Gupte, A. | Al-Antary, E. | Edwards, H. | +3

3

Improved outcomes for myeloid leukemia of Down syndrome : a report from the Children's Oncology Group AAML0431 trial

enthalten in: Blood | 2017

von Taub, J. | Berman, J. | Hitzler, J. | +14

CommentIn: Blood. 2017 Jun 22;129(25):3273-3274. - PMID 28642354

4

Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells

enthalten in: Scientific reports | 2017

von Ma, J. | Li, X. | Su, Y. | +11

5

Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells

enthalten in: Oncotarget | 2017

von Zhao, J. | Xie, C. | Edwards, H. | +3

6

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Niu, X. | Zhao, J. | Ma, J. | +11

7

Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage

enthalten in: Molecular oncology | 2015

von Xie, C. | Edwards, H. | Caldwell, J. | +3

8

Prognosis and management of acute myeloid leukemia in patients with Down syndrome

enthalten in: Expert review of hematology | 2014

von Caldwell, J. | Ge, Y. | Taub, J.

9

Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia

enthalten in: Pediatric blood & cancer | 2014

von Caldwell, J. | Edwards, H. | Buck, S. | +2

10

AAML0523 : a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

enthalten in: Cancer | 2014

von Cooper, T. | Alonzo, T. | Gerbing, R. | +8